Your browser doesn't support javascript.
loading
A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma.
Bolcaen, Julie; Kleynhans, Janke; Nair, Shankari; Verhoeven, Jeroen; Goethals, Ingeborg; Sathekge, Mike; Vandevoorde, Charlot; Ebenhan, Thomas.
Affiliation
  • Bolcaen J; Radiobiology, Radiation Biophysics Division, Nuclear Medicine Department, iThemba LABS, Cape Town, South Africa.
  • Kleynhans J; Nuclear Medicine Research Infrastructure NPC, Pretoria, South Africa.
  • Nair S; Nuclear Medicine Department, University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa.
  • Verhoeven J; Radiobiology, Radiation Biophysics Division, Nuclear Medicine Department, iThemba LABS, Cape Town, South Africa.
  • Goethals I; Laboratory of Radiopharmacy, Ghent University, Ghent, Belgium.
  • Sathekge M; Ghent University Hospital, Department of Nuclear Medicine, Ghent, Belgium.
  • Vandevoorde C; Nuclear Medicine Research Infrastructure NPC, Pretoria, South Africa.
  • Ebenhan T; Nuclear Medicine Department, University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa.
Theranostics ; 11(16): 7911-7947, 2021.
Article in En | MEDLINE | ID: mdl-34335972
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glioblastoma / Radiopharmaceuticals Type of study: Prognostic_studies Limits: Humans Language: En Journal: Theranostics Year: 2021 Document type: Article Affiliation country: South Africa Country of publication: Australia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glioblastoma / Radiopharmaceuticals Type of study: Prognostic_studies Limits: Humans Language: En Journal: Theranostics Year: 2021 Document type: Article Affiliation country: South Africa Country of publication: Australia